Person · CIK 1529196

Mark J Foley

Director at GLAUKOS; President & CEO at Revance Therapeutics

Earlier: SI-BONE and Zeltiq Aesthetics

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$31.4M

Noticed on Form 144$7.5M

Bought on Form 4$1.3M

Companies4

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

Company	Security	Held	Shares or units	As of
GLAUKOS GKOS	Common Stock	Directly	60,267	May 28, 2026 · Filing · EDGAR
GLAUKOS GKOS	Stock Option (Right to Buy) exercise $106.52, expires May 28, 2036, into Common Stock	Directly	2,987	May 28, 2026 · Filing · EDGAR
Revance Therapeutics RVNC	Performance Stock Units expires Jan 31, 2028, into Common Stock	Directly	1,070,001	Jan 31, 2024 · Filing · EDGAR
SI-BONE	Common Stock	Directly	8,797	Jun 16, 2020 · Filing · EDGAR
SI-BONE	Stock Options (Right to buy) exercise $17.72, expires Jun 12, 2029, into Common Stock	Directly	26,236	Jun 13, 2019 · Filing · EDGAR

Sold and noticed by quarter

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table

Quarter	Sold (Form 4)	Noticed (Form 144)	Bought (Form 4)
Q1 2025	$2.5M	$2.5M	—
Q1 2024	$423K	$423K	$209K
Q3 2023	$1.2M	$1.2M	—
Q2 2023	$3.4M	$3.3M	—
Q1 2023	$2.2M	Not machine-readable	—
Q4 2021	—	—	$516K
Q4 2017	—	—	$539K
Q1 2017	$1.5M	Not machine-readable	—
Q4 2016	$1.2M	Not machine-readable	—
Q3 2016	$4.7M	Not machine-readable	—
Q2 2016	$401K	Not machine-readable	—
Q1 2016	$1M	Not machine-readable	—
Q4 2015	$1.3M	Not machine-readable	—
Q3 2015	$5M	Not machine-readable	—
Q2 2015	$380K	Not machine-readable	—
Q1 2015	$2.7M	Not machine-readable	—
Q4 2014	$1.3M	Not machine-readable	—
Q3 2014	$2.1M	Not machine-readable	—
Q2 2014	$130K	Not machine-readable	—

Form 144 notices went onto EDGAR as structured data on April 13, 2023. Earlier notices were filed on paper and cannot be read here, so those quarters show no noticed amount.

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice date	Noticed	Planned sale	Outcome	Links
GLAUKOS GKOS · Fidelity Brokerage Services · No 10b5-1 plan stated · 2 notices
Feb 26, 2025	20,687 · ~$2.5M	Feb 26, 2025	Sold as noticed Sold 20,687 at $120.72 on Feb 26 · $2.5M Form 4	Filing · EDGAR
Feb 23, 2024	4,560 · ~$423K	Feb 23, 2024	Sold as noticed Sold 4,560 at $92.87 on Feb 23 · $423K Form 4	Filing · EDGAR
Revance Therapeutics RVNC · E*Trade Financial · 10b5-1 plan adopted Mar 10, 2023 · 3 notices
Aug 3, 2023	26,279 · ~$591K	Aug 3, 2023	Sold as noticed Sold 26,279 at $22.57 on Aug 3 · $593K Form 4	Filing · EDGAR
Jul 3, 2023	26,279 · ~$655K	Jul 3, 2023	Sold as noticed Sold 26,279 at $24.94 on Jul 3 · $655K Form 4	Filing · EDGAR
Jun 9, 2023	31,279 · ~$961K	Jun 9, 2023	Sold as noticed Sold 31,279 at $30.72 on Jun 9 · $961K Form 4	Filing · EDGAR
Revance Therapeutics RVNC · E*Trade Financial · No 10b5-1 plan stated · 2 notices
May 15, 2023	447 · ~$15K	May 15, 2023	Not sold within 90 days	Filing · EDGAR
May 12, 2023	70,000 · ~$2.3M	May 12, 2023	Sold as noticed Sold 70,447 at $34.55 on May 15 · $2.4M Form 4	Filing · EDGAR
Sales without a matching Form 144 · 67 sales No matching Form 144 found. Not every sale needs one: small sales and sales by people who are not affiliates are exempt.
—	—	—	Notice not machine-readable Revance Therapeutics (RVNC): Sold 70,390 at $31.59 on Mar 9, 2023 · $2.2M	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 10,000 at $55.77 on Mar 13, 2017 · $558K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 10,000 at $55.69 on Feb 13, 2017 · $557K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 10,000 at $41.72 on Jan 13, 2017 · $417K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 10,000 at $44.08 on Dec 13, 2016 · $441K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 10,000 at $39.54 on Nov 14, 2016 · $395K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 3,800 at $40.89 on Oct 13, 2016 · $155K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 6,200 at $40.34 on Oct 13, 2016 · $250K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 10,000 at $37.69 on Sep 13, 2016 · $377K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 10,000 at $37.26 on Aug 15, 2016 · $373K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 7,759 at $38.89 on Aug 9, 2016 · $302K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 42,241 at $37.71 on Aug 9, 2016 · $1.6M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 47,330 at $35.01 on Aug 5, 2016 · $1.7M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 2,670 at $35.06 on Aug 4, 2016 · $94K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 1,200 at $31.93 on Jul 13, 2016 · $38K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 8,800 at $31.12 on Jul 13, 2016 · $274K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 13,640 at $29.39 on Apr 13, 2016 · $401K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 9,698 at $25.01 on Mar 22, 2016 · $243K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 16,302 at $25.03 on Mar 21, 2016 · $408K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 1,272 at $25.01 on Mar 18, 2016 · $32K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 200 at $27.05 on Jan 13, 2016 · $5K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 13,436 at $26.38 on Jan 13, 2016 · $354K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 4,946 at $28.71 on Dec 14, 2015 · $142K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 8,690 at $27.65 on Dec 14, 2015 · $240K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 4,822 at $32.62 on Nov 13, 2015 · $157K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 8,814 at $31.92 on Nov 13, 2015 · $281K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 13,636 at $31.80 on Oct 13, 2015 · $434K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 200 at $35.83 on Sep 14, 2015 · $7K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 200 at $35.79 on Sep 14, 2015 · $7K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 13,236 at $35.28 on Sep 14, 2015 · $467K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 13,636 at $35.02 on Aug 13, 2015 · $478K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 50,000 at $37.54 on Aug 5, 2015 · $1.9M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 14,959 at $35.15 on Aug 3, 2015 · $526K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 700 at $36.60 on Jul 31, 2015 · $26K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 1,200 at $36.11 on Jul 31, 2015 · $43K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 33,141 at $35.07 on Jul 31, 2015 · $1.2M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 1,867 at $29.37 on Jul 13, 2015 · $55K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 11,769 at $28.89 on Jul 13, 2015 · $340K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 13,636 at $27.85 on Jun 15, 2015 · $380K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 7,123 at $34.30 on Feb 17, 2015 · $244K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 7,200 at $30.43 on Jan 20, 2015 · $219K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 29,200 at $30.33 on Jan 20, 2015 · $886K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 5,070 at $29.53 on Jan 14, 2015 · $150K	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 2,053 at $28.57 on Jan 14, 2015 · $59K	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 6,400 at $30.05 on Jan 12, 2015 · $192K	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 30,100 at $30.19 on Jan 9, 2015 · $909K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 2,100 at $30.00 on Dec 18, 2014 · $63K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 7,123 at $28.97 on Dec 15, 2014 · $206K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 7,123 at $26.92 on Nov 14, 2014 · $192K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 9,300 at $26.15 on Oct 29, 2014 · $243K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 15,700 at $25.61 on Oct 29, 2014 · $402K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 804 at $21.96 on Oct 14, 2014 · $18K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 6,319 at $21.56 on Oct 14, 2014 · $136K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 200 at $26.55 on Sep 15, 2014 · $5K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 323 at $26.45 on Sep 15, 2014 · $9K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 100 at $26.43 on Sep 15, 2014 · $3K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 400 at $26.36 on Sep 15, 2014 · $11K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 6,100 at $25.73 on Sep 15, 2014 · $157K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 300 at $26.10 on Sep 11, 2014 · $8K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 300 at $26.05 on Sep 11, 2014 · $8K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 49,400 at $25.46 on Sep 11, 2014 · $1.3M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 7,123 at $19.57 on Aug 14, 2014 · $139K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 18,769 at $21.62 on Jul 30, 2014 · $406K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 2,500 at $20.63 on Jul 30, 2014 · $52K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 100 at $18.00 on May 30, 2014 · $2K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 3,800 at $18.07 on Apr 16, 2014 · $69K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Zeltiq Aesthetics: Sold 3,323 at $18.03 on Apr 14, 2014 · $60K (10b5-1 plan)	Filing · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

GLAUKOS GKOS Director · filings 2015 to 2026 · sold $2.9M · $2.9M noticed on Form 144

Date	Transaction	Shares	Price	Value	Held after	Source
May 28, 2026	Grant or award from the company Stock Option (Right to Buy)	+2,987			2,987 direct	Filing · EDGAR
May 28, 2026	Grant or award from the company	+1,878			60,267 direct	Filing · EDGAR
Jan 2, 2026	Grant or award from the company	+1,168			58,389 direct	Filing · EDGAR
May 29, 2025	Grant or award from the company	+2,108			57,221 direct	Filing · EDGAR
May 29, 2025	Grant or award from the company Stock Option (Right to Buy)	+3,149			3,149 direct	Filing · EDGAR
Feb 26, 2025	Option or RSU exercised or converted	+25,000	$32.00	$800K	59,936 direct	Filing · EDGAR
Feb 26, 2025	Option or RSU exercised or converted	+15,000	$24.69	$370K	74,936 direct	Filing · EDGAR
Feb 26, 2025	Open-market or private sale	−20,687	$120.72	$2.5M	54,249 direct	Filing · EDGAR
Feb 26, 2025	Option or RSU exercised or converted Stock Option (Right to Buy)	−25,000			0 direct	Filing · EDGAR
Feb 26, 2025	Option or RSU exercised or converted Stock Option (Right to Buy)	−15,000			0 direct	Filing · EDGAR
Jan 2, 2025	Grant or award from the company	+864			35,800 direct	Filing · EDGAR
May 30, 2024	Grant or award from the company	+1,716			34,936 direct	Filing · EDGAR
May 30, 2024	Grant or award from the company Stock Option (Right to Buy)	+1,246			1,246 direct	Filing · EDGAR
Feb 23, 2024	Option or RSU exercised or converted	+10,000	$7.28	$73K	37,780 direct	Filing · EDGAR
Feb 23, 2024	Open-market or private sale	−4,560	$92.87	$423K	33,220 direct	Filing · EDGAR
Feb 23, 2024	Option or RSU exercised or converted Stock Option (Right to Buy)	−10,000			0 direct	Filing · EDGAR
Jun 1, 2023	Grant or award from the company	+3,230			27,780 direct	Filing · EDGAR
Jan 3, 2023	Grant or award from the company	+2,948			24,550 direct	Filing · EDGAR
Jun 2, 2022	Grant or award from the company	+4,364			21,602 direct	Filing · EDGAR
Jan 3, 2022	Grant or award from the company	+2,486			17,238 direct	Filing · EDGAR
Jun 3, 2021	Grant or award from the company	+2,382			14,752 direct	Filing · EDGAR
Jan 4, 2021	Grant or award from the company	+1,184			12,370 direct	Filing · EDGAR
Jun 3, 2020	Grant or award from the company	+3,900			11,186 direct	Filing · EDGAR
May 30, 2019	Grant or award from the company	+2,653			7,286 direct	Filing · EDGAR
May 31, 2018	Grant or award from the company	+4,633			4,633 direct	Filing · EDGAR
Dec 13, 2017	Grant or award from the company Stock option (right to buy)	+15,000			15,000 direct	Filing · EDGAR
Jun 2, 2016	Grant or award from the company Stock option (right to buy)	+15,000			15,000 direct	Filing · EDGAR
Jul 23, 2015	Grant or award from the company Stock option (right to buy)	+25,000			25,000 direct	Filing · EDGAR

Revance Therapeutics RVNC President & CEO · filings 2017 to 2025 · sold $6.9M · bought $1.3M · $4.6M noticed on Form 144

Date	Transaction	Shares	Price	Value	Held after	Source
Feb 6, 2025	Returned to the company	−27,933			0 direct	Filing · EDGAR
Feb 6, 2025	Grant or award from the company	+84,686			84,686 direct	Filing · EDGAR
Feb 6, 2025	Returned to the company	−84,686			0 direct	Filing · EDGAR
Feb 4, 2025	Tendered in a change of control	−996,935	$3.65	$3.6M	27,933 direct	Filing · EDGAR
Feb 4, 2025	Tendered in a change of control	−110,913	$3.65	$405K	0 See footnote	Filing · EDGAR
Feb 3, 2025	Grant or award from the company	+27,933			1,024,868 direct	Filing · EDGAR
Dec 31, 2024	Grant or award from the company	+1,000	$2.18	$2K	996,935 direct	Filing · EDGAR
Jun 30, 2024	Grant or award from the company	+1,000	$2.18	$2K	995,935 direct	Filing · EDGAR
Mar 15, 2024	Shares withheld for tax or exercise price	−3,305	$5.31	$18K	1,012,163 direct	Filing · EDGAR
Mar 15, 2024	Shares withheld for tax or exercise price	−17,228	$5.31	$91K	994,935 direct	Filing · EDGAR
Mar 6, 2024	Open-market or private purchase	+30,000	$6.98	$209K	1,015,468 direct	Filing · EDGAR
Feb 29, 2024	Grant or award from the company	+70,750			985,468 direct	Filing · EDGAR
Jan 31, 2024	Grant or award from the company Performance Stock Units	+1,070,001			1,070,001 direct	Filing · EDGAR
Dec 31, 2023	Grant or award from the company	+264	$7.47	$2K	914,718 direct	Filing · EDGAR
Aug 11, 2023	Grant or award from the company	+122,143			962,518 direct	Filing · EDGAR
Aug 11, 2023	Shares withheld for tax or exercise price	−48,064	$18.91	$909K	914,454 direct	Filing · EDGAR
Aug 3, 2023	Sale under a 10b5-1 plan	−26,279	$22.57	$593K	840,375 direct	Filing · EDGAR
Jul 3, 2023	Sale under a 10b5-1 plan	−26,279	$24.94	$655K	866,654 direct	Filing · EDGAR
Jun 30, 2023	Grant or award from the company	+1,000	$15.61	$16K	892,933 direct	Filing · EDGAR
Jun 9, 2023	Sale under a 10b5-1 plan	−31,279	$30.72	$961K	891,933 direct	Filing · EDGAR
May 15, 2023	Open-market or private sale	−70,447	$34.55	$2.4M	923,212 direct	Filing · EDGAR
Mar 15, 2023	Shares withheld for tax or exercise price	−5,341	$30.65	$164K	818,010 direct	Filing · EDGAR
Mar 9, 2023	Open-market or private sale	−70,390	$31.59	$2.2M	823,351 direct	Filing · EDGAR
Dec 31, 2022	Grant or award from the company	+605	$12.18	$7K	718,092 direct	Filing · EDGAR
Oct 13, 2022	Shares withheld for tax or exercise price	−49,274	$26.97	$1.3M	717,487 direct	Filing · EDGAR
Sep 22, 2022	Grant or award from the company	+175,649			893,741 direct	Filing · EDGAR
Jun 30, 2022	Grant or award from the company	+1,000	$11.75	$12K	766,761 direct	Filing · EDGAR
Mar 15, 2022	Shares withheld for tax or exercise price	−3,304	$15.79	$52K	765,761 direct	Filing · EDGAR
Feb 2, 2022	Grant or award from the company	+175,649			993,659 direct	Filing · EDGAR
Feb 2, 2022	Grant or award from the company Employee Stock Option (Right to Buy)	+143,354			143,354 direct	Filing · EDGAR
Nov 29, 2021	Open-market or private purchase	+40,000	$12.90	$516K	110,913 See footnote	Filing · EDGAR
Oct 13, 2021	Shares withheld for tax or exercise price	−42,096	$23.08	$972K	769,065 direct	Filing · EDGAR
Jun 30, 2021	Other acquisition or disposition (see the filing)	+882	$24.09	$21K	811,161 direct	Filing · EDGAR
Feb 2, 2021	Grant or award from the company	+40,715			810,279 direct	Filing · EDGAR
Feb 2, 2021	Grant or award from the company Employee Stock Option (Right to Buy)	+73,665			73,665 direct	Filing · EDGAR
Oct 13, 2020	Shares withheld for tax or exercise price	−66,106	$27.62	$1.8M	769,564 direct	Filing · EDGAR
Sep 30, 2020	Grant or award from the company	+301,000			714,500 direct	Filing · EDGAR
Sep 30, 2020	Shares withheld for tax or exercise price	−143,269	$25.14	$3.6M	571,231 direct	Filing · EDGAR
Jul 23, 2020	Grant or award from the company	+264,439			835,670 direct	Filing · EDGAR
Jul 23, 2020	Grant or award from the company	+50,913			70,913 See footnote	Filing · EDGAR
Jan 23, 2020	Grant or award from the company	+200,000			413,500 direct	Filing · EDGAR
Oct 13, 2019	Grant or award from the company	+200,000			213,500 direct	Filing · EDGAR
Oct 13, 2019	Grant or award from the company Employee Stock Option (Right to Buy)	+740,000			740,000 direct	Filing · EDGAR
May 9, 2019	Grant or award from the company	+4,500			13,500 direct	Filing · EDGAR
May 9, 2019	Grant or award from the company Stock Option (Right to buy)	+9,000			18,000 direct	Filing · EDGAR
May 10, 2018	Grant or award from the company	+3,000			9,000 direct	Filing · EDGAR
May 10, 2018	Grant or award from the company Stock Option (Right to buy)	+6,000			6,000 direct	Filing · EDGAR
Nov 7, 2017	Open-market or private purchase	+19,500	$26.95	$525K	19,500 See footnote	Filing · EDGAR
Nov 7, 2017	Open-market or private purchase	+500	$27.45	$14K	20,000 See footnote	Filing · EDGAR
Sep 5, 2017	Grant or award from the company	+6,000			6,000 direct	Filing · EDGAR
Sep 5, 2017	Grant or award from the company Stock Option (Right to Buy)	+12,000			12,000 direct	Filing · EDGAR

SI-BONE Director · filings 2019 to 2020

Date	Transaction	Shares	Price	Value	Held after	Source
Jun 16, 2020	Grant or award from the company	+8,797			8,797 direct	Filing · EDGAR
Jun 13, 2019	Grant or award from the company Stock Options (Right to buy)	+26,236			26,236 direct	Filing · EDGAR

Zeltiq Aesthetics President and CEO · filings 2011 to 2017 · sold $21.6M

Date	Transaction	Shares	Price	Value	Held after	Source
Apr 28, 2017	Returned to the company	−173,787	$56.50	$9.8M	0 direct	Filing · EDGAR
Apr 28, 2017	Returned to the company Stock Option (Right to Buy)	−572,435			0 direct	Filing · EDGAR
Apr 28, 2017	Returned to the company Stock Option (Right to Buy)	−758,667			0 direct	Filing · EDGAR
Apr 28, 2017	Returned to the company Stock Option (Right to Buy)	−9,536			0 direct	Filing · EDGAR
Apr 28, 2017	Returned to the company Stock Option (Right to Buy)	−121,236			0 direct	Filing · EDGAR
Apr 28, 2017	Returned to the company Stock Option (Right to Buy)	−20,000			0 direct	Filing · EDGAR
Apr 28, 2017	Returned to the company Stock Option (Right to Buy)	−26,277			0 direct	Filing · EDGAR
Apr 28, 2017	Returned to the company Stock Option (Right to Buy)	−124,610			0 direct	Filing · EDGAR
Apr 28, 2017	Returned to the company Stock Option (Right to Buy)	−72,254			0 direct	Filing · EDGAR
Apr 7, 2017	Gift	−37,667			173,787 direct	Filing · EDGAR
Mar 13, 2017	Sale under a 10b5-1 plan	−10,000	$55.77	$558K	220,430 direct	Filing · EDGAR
Mar 13, 2017	Gift	−8,976			211,454 direct	Filing · EDGAR
Feb 24, 2017	Shares withheld for tax or exercise price	−4,565	$55.62	$254K	230,430 direct	Filing · EDGAR
Feb 19, 2017	Shares withheld for tax or exercise price	−4,962	$55.67	$276K	242,838 direct	Filing · EDGAR
Feb 19, 2017	Shares withheld for tax or exercise price	−7,843	$55.67	$437K	234,995 direct	Filing · EDGAR
Feb 13, 2017	Sale under a 10b5-1 plan	−10,000	$55.69	$557K	247,800 direct	Filing · EDGAR
Jan 18, 2017	Grant or award from the company	+37,861			257,800 direct	Filing · EDGAR
Jan 18, 2017	Grant or award from the company Stock Option (right to buy)	+72,254			72,254 direct	Filing · EDGAR
Jan 13, 2017	Sale under a 10b5-1 plan	−10,000	$41.72	$417K	219,939 direct	Filing · EDGAR
Dec 14, 2016	Gift	−22,500			229,939 direct	Filing · EDGAR
Dec 13, 2016	Sale under a 10b5-1 plan	−10,000	$44.08	$441K	252,439 direct	Filing · EDGAR
Nov 14, 2016	Sale under a 10b5-1 plan	−10,000	$39.54	$395K	261,941 direct	Filing · EDGAR
Oct 13, 2016	Shares withheld for tax or exercise price	−4,666	$40.83	$191K	281,941 direct	Filing · EDGAR
Oct 13, 2016	Sale under a 10b5-1 plan	−6,200	$40.34	$250K	275,741 direct	Filing · EDGAR
Oct 13, 2016	Sale under a 10b5-1 plan	−3,800	$40.89	$155K	271,941 direct	Filing · EDGAR
Sep 13, 2016	Shares withheld for tax or exercise price	−4,667	$38.06	$178K	296,607 direct	Filing · EDGAR
Sep 13, 2016	Sale under a 10b5-1 plan	−10,000	$37.69	$377K	286,607 direct	Filing · EDGAR
Aug 15, 2016	Sale under a 10b5-1 plan	−10,000	$37.26	$373K	301,274 direct	Filing · EDGAR
Aug 13, 2016	Shares withheld for tax or exercise price	−4,666	$37.84	$177K	311,274 direct	Filing · EDGAR
Aug 9, 2016	Option or RSU exercised or converted	+50,000	$5.04	$252K	365,940 direct	Filing · EDGAR
Aug 9, 2016	Sale under a 10b5-1 plan	−42,241	$37.71	$1.6M	323,699 direct	Filing · EDGAR
Aug 9, 2016	Sale under a 10b5-1 plan	−7,759	$38.89	$302K	315,940 direct	Filing · EDGAR
Aug 9, 2016	Option or RSU exercised or converted Stock Option (Right to Buy)	−50,000			758,667 direct	Filing · EDGAR
Aug 5, 2016	Option or RSU exercised or converted	+47,330	$5.04	$239K	363,270 direct	Filing · EDGAR
Aug 5, 2016	Sale under a 10b5-1 plan	−47,330	$35.01	$1.7M	315,940 direct	Filing · EDGAR
Aug 5, 2016	Option or RSU exercised or converted Stock Option (Right to Buy)	−47,330			808,667 direct	Filing · EDGAR
Aug 4, 2016	Option or RSU exercised or converted	+2,670	$5.04	$13K	318,610 direct	Filing · EDGAR
Aug 4, 2016	Sale under a 10b5-1 plan	−2,670	$35.06	$94K	315,940 direct	Filing · EDGAR
Aug 4, 2016	Option or RSU exercised or converted Stock Option (Right to Buy)	−2,670			855,997 direct	Filing · EDGAR
Jul 13, 2016	Shares withheld for tax or exercise price	−4,667	$31.45	$147K	325,940 direct	Filing · EDGAR
Jul 13, 2016	Sale under a 10b5-1 plan	−8,800	$31.12	$274K	317,140 direct	Filing · EDGAR
Jul 13, 2016	Sale under a 10b5-1 plan	−1,200	$31.93	$38K	315,940 direct	Filing · EDGAR
Jun 13, 2016	Shares withheld for tax or exercise price	−4,666	$28.19	$132K	330,607 direct	Filing · EDGAR
May 13, 2016	Shares withheld for tax or exercise price	−4,666	$24.35	$114K	334,757 direct	Filing · EDGAR
Apr 13, 2016	Shares withheld for tax or exercise price	−4,667	$30.34	$142K	353,063 direct	Filing · EDGAR
Apr 13, 2016	Sale under a 10b5-1 plan	−13,640	$29.39	$401K	339,423 direct	Filing · EDGAR
Mar 22, 2016	Sale under a 10b5-1 plan	−9,698	$25.01	$243K	357,730 direct	Filing · EDGAR
Mar 21, 2016	Sale under a 10b5-1 plan	−16,302	$25.03	$408K	367,428 direct	Filing · EDGAR
Mar 18, 2016	Sale under a 10b5-1 plan	−1,272	$25.01	$32K	383,730 direct	Filing · EDGAR
Mar 13, 2016	Shares withheld for tax or exercise price	−4,666	$23.23	$108K	385,002 direct	Filing · EDGAR
Feb 29, 2016	Grant or award from the company	+65,421			389,668 direct	Filing · EDGAR
Feb 29, 2016	Grant or award from the company Employee Stock Option (right to buy)	+124,610			124,610 direct	Filing · EDGAR
Feb 24, 2016	Shares withheld for tax or exercise price	−3,288	$22.37	$74K	324,247 direct	Filing · EDGAR
Feb 19, 2016	Shares withheld for tax or exercise price	−4,937	$20.69	$102K	327,535 direct	Filing · EDGAR
Feb 12, 2016	Shares withheld for tax or exercise price	−3,361	$19.26	$65K	332,472 direct	Filing · EDGAR
Jan 13, 2016	Shares withheld for tax or exercise price	−3,554	$26.62	$95K	349,469 direct	Filing · EDGAR
Jan 13, 2016	Sale under a 10b5-1 plan	−13,436	$26.38	$354K	336,033 direct	Filing · EDGAR
Jan 13, 2016	Sale under a 10b5-1 plan	−200	$27.05	$5K	335,833 direct	Filing · EDGAR
Dec 14, 2015	Sale under a 10b5-1 plan	−8,690	$27.65	$240K	357,959 direct	Filing · EDGAR
Dec 14, 2015	Sale under a 10b5-1 plan	−4,946	$28.71	$142K	353,023 direct	Filing · EDGAR

114 earlier transactions are in the filing list below.

All 138 Forms 3, 4, 5 and 144

Filed	Form	Company	Links
Jun 23, 2026	Form 4/A	GLAUKOS GKOS	Filing · EDGAR
Jun 1, 2026	Form 4	GLAUKOS GKOS	Filing · EDGAR
Jan 7, 2026	Form 4	GLAUKOS GKOS	Filing · EDGAR
Jun 2, 2025	Form 4	GLAUKOS GKOS	Filing · EDGAR
Feb 28, 2025	Form 4	GLAUKOS GKOS	Filing · EDGAR
Feb 26, 2025	Form 144	GLAUKOS GKOS	Filing · EDGAR
Feb 6, 2025	Form 4	Revance Therapeutics RVNC	Filing · EDGAR
Feb 5, 2025	Form 4	Revance Therapeutics RVNC	Filing · EDGAR
Jan 3, 2025	Form 4	Revance Therapeutics RVNC	Filing · EDGAR
Jul 2, 2024	Form 4	Revance Therapeutics RVNC	Filing · EDGAR
Jun 3, 2024	Form 4	GLAUKOS GKOS	Filing · EDGAR
Mar 19, 2024	Form 4	Revance Therapeutics RVNC	Filing · EDGAR
Mar 8, 2024	Form 4	Revance Therapeutics RVNC	Filing · EDGAR
Mar 4, 2024	Form 4	Revance Therapeutics RVNC	Filing · EDGAR
Feb 26, 2024	Form 4	GLAUKOS GKOS	Filing · EDGAR
Feb 23, 2024	Form 144	GLAUKOS GKOS	Filing · EDGAR
Feb 2, 2024	Form 4	Revance Therapeutics RVNC	Filing · EDGAR
Jan 3, 2024	Form 4	Revance Therapeutics RVNC	Filing · EDGAR
Aug 15, 2023	Form 4	Revance Therapeutics RVNC	Filing · EDGAR
Aug 4, 2023	Form 4	Revance Therapeutics RVNC	Filing · EDGAR
Aug 3, 2023	Form 144	Revance Therapeutics RVNC	Filing · EDGAR
Jul 5, 2023	Form 4	Revance Therapeutics RVNC	Filing · EDGAR
Jul 3, 2023	Form 144	Revance Therapeutics RVNC	Filing · EDGAR
Jun 13, 2023	Form 4	Revance Therapeutics RVNC	Filing · EDGAR
Jun 9, 2023	Form 144	Revance Therapeutics RVNC	Filing · EDGAR
Jun 5, 2023	Form 4	GLAUKOS GKOS	Filing · EDGAR
May 16, 2023	Form 4	Revance Therapeutics RVNC	Filing · EDGAR
May 15, 2023	Form 144	Revance Therapeutics RVNC	Filing · EDGAR
May 12, 2023	Form 144	Revance Therapeutics RVNC	Filing · EDGAR
Mar 17, 2023	Form 4	Revance Therapeutics RVNC	Filing · EDGAR
Mar 9, 2023	Form 4	Revance Therapeutics RVNC	Filing · EDGAR
Mar 9, 2023	Form 144	Could not read	EDGAR
Jan 4, 2023	Form 4	GLAUKOS GKOS	Filing · EDGAR
Jan 3, 2023	Form 4	Revance Therapeutics RVNC	Filing · EDGAR
Oct 14, 2022	Form 4	Revance Therapeutics RVNC	Filing · EDGAR
Jul 5, 2022	Form 4	Revance Therapeutics RVNC	Filing · EDGAR
Jun 6, 2022	Form 4	GLAUKOS GKOS	Filing · EDGAR
Mar 17, 2022	Form 4	Revance Therapeutics RVNC	Filing · EDGAR
Feb 4, 2022	Form 4	Revance Therapeutics RVNC	Filing · EDGAR
Jan 5, 2022	Form 4	GLAUKOS GKOS	Filing · EDGAR
Nov 29, 2021	Form 4	Revance Therapeutics RVNC	Filing · EDGAR
Oct 15, 2021	Form 4	Revance Therapeutics RVNC	Filing · EDGAR
Jul 2, 2021	Form 4	Revance Therapeutics RVNC	Filing · EDGAR
Jun 7, 2021	Form 4	GLAUKOS GKOS	Filing · EDGAR
Feb 4, 2021	Form 4	Revance Therapeutics RVNC	Filing · EDGAR
Jan 6, 2021	Form 4	GLAUKOS GKOS	Filing · EDGAR
Oct 15, 2020	Form 4	Revance Therapeutics RVNC	Filing · EDGAR
Oct 2, 2020	Form 4	Revance Therapeutics RVNC	Filing · EDGAR
Jun 18, 2020	Form 4	SI-BONE	Filing · EDGAR
Jun 5, 2020	Form 4	GLAUKOS GKOS	Filing · EDGAR
Feb 19, 2020	Form 4/A	Revance Therapeutics RVNC	Filing · EDGAR
Jan 24, 2020	Form 4	Revance Therapeutics RVNC	Filing · EDGAR
Oct 15, 2019	Form 4	Revance Therapeutics RVNC	Filing · EDGAR
Jun 17, 2019	Form 4	SI-BONE	Filing · EDGAR
Jun 17, 2019	Form 3	SI-BONE	Filing · EDGAR
May 31, 2019	Form 4	GLAUKOS GKOS	Filing · EDGAR
May 10, 2019	Form 4	Revance Therapeutics RVNC	Filing · EDGAR
Jun 1, 2018	Form 4	GLAUKOS GKOS	Filing · EDGAR
May 11, 2018	Form 4	Revance Therapeutics RVNC	Filing · EDGAR
Dec 14, 2017	Form 4	GLAUKOS GKOS	Filing · EDGAR
Nov 9, 2017	Form 4	Revance Therapeutics RVNC	Filing · EDGAR
Sep 7, 2017	Form 4	Revance Therapeutics RVNC	Filing · EDGAR
Sep 7, 2017	Form 3	Revance Therapeutics RVNC	Filing · EDGAR
Apr 28, 2017	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Apr 12, 2017	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Mar 14, 2017	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Feb 27, 2017	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Feb 22, 2017	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Feb 15, 2017	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Jan 20, 2017	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Jan 17, 2017	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Dec 15, 2016	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Nov 15, 2016	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Oct 14, 2016	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Sep 14, 2016	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Aug 16, 2016	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Aug 10, 2016	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Aug 8, 2016	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Jul 14, 2016	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Jun 14, 2016	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Jun 3, 2016	Form 4	GLAUKOS GKOS	Filing · EDGAR
May 16, 2016	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Apr 14, 2016	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Mar 23, 2016	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Mar 22, 2016	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Mar 14, 2016	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Mar 2, 2016	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Feb 24, 2016	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Feb 23, 2016	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Feb 16, 2016	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Jan 14, 2016	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Dec 15, 2015	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Nov 23, 2015	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Nov 16, 2015	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Oct 14, 2015	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Sep 15, 2015	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Aug 14, 2015	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Aug 6, 2015	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Aug 4, 2015	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Jul 24, 2015	Form 4	GLAUKOS GKOS	Filing · EDGAR
Jul 14, 2015	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Jun 24, 2015	Form 3	GLAUKOS GKOS	Filing · EDGAR
Jun 15, 2015	Form 4	Zeltiq Aesthetics	Filing · EDGAR
May 14, 2015	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Apr 14, 2015	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Mar 16, 2015	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Feb 25, 2015	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Feb 23, 2015	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Feb 18, 2015	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Jan 21, 2015	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Jan 15, 2015	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Jan 13, 2015	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Dec 19, 2014	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Dec 15, 2014	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Nov 17, 2014	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Oct 30, 2014	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Oct 15, 2014	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Sep 15, 2014	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Aug 15, 2014	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Jul 31, 2014	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Jul 15, 2014	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Jun 16, 2014	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Jun 2, 2014	Form 4	Zeltiq Aesthetics	Filing · EDGAR
May 15, 2014	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Apr 16, 2014	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Mar 17, 2014	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Mar 4, 2014	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Feb 26, 2014	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Feb 14, 2014	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Jan 21, 2014	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Dec 16, 2013	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Nov 15, 2013	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Oct 16, 2013	Form 4/A	Zeltiq Aesthetics	Filing · EDGAR
Oct 15, 2013	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Aug 28, 2012	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Jun 18, 2012	Form 4	Zeltiq Aesthetics	Filing · EDGAR
May 1, 2012	Form 4	Zeltiq Aesthetics	Filing · EDGAR
Oct 18, 2011	Form 3	Zeltiq Aesthetics	Filing · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched Nov 8, 2026, 7:38 AM ET. The filing on SEC.gov is the record.